Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06775327 · ClinicalTrials.gov registry record · Phase 1
Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants
A Phase 1 study, sponsored by Incyte Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 71
- Enrollment target
NCT06775327 is a Phase 1 study that has completed, run by Incyte Corporation. The registered enrollment target is 71 participants.
The verdict
NCT06775327, a Phase 1 study, has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study will be conducted to assess the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics, and Food Effect of INCB000631 When Administered Orally to Healthy Adult Participants.
Interventions
- DRUG Placebo
- DRUG INCB000631
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2025-05-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06775327
The ClinicalTrials.gov registry entry for NCT06775327 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06775327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06775327 about?
NCT06775327 is a clinical study titled "Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants". This study will be conducted to assess the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics, and Food Effect of INCB000631 When Administered Orally to Healthy Adult Participants.
What is the current status of trial NCT06775327?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 71 participants. The study started on 2025-02-13. Estimated completion is 2025-05-28.
What interventions are being tested in trial NCT06775327?
The interventions under investigation include: Placebo (DRUG), INCB000631 (DRUG).
Who is sponsoring clinical trial NCT06775327?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.